Historical Valuation
Addus Homecare Corp (ADUS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.91 is considered Undervalued compared with the five-year average of 22.00. The fair price of Addus Homecare Corp (ADUS) is between 145.51 to 190.87 according to relative valuation methord. Compared to the current price of 112.33 USD , Addus Homecare Corp is Undervalued By 22.8%.
Relative Value
Fair Zone
145.51-190.87
Current Price：112.33
22.8%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Addus Homecare Corp (ADUS) has a current Price-to-Book (P/B) ratio of 1.85. Compared to its 3-year average P/B ratio of 2.21 , the current P/B ratio is approximately -16.30% higher. Relative to its 5-year average P/B ratio of 2.37, the current P/B ratio is about -22.00% higher. Addus Homecare Corp (ADUS) has a Forward Free Cash Flow (FCF) yield of approximately 4.96%. Compared to its 3-year average FCF yield of 5.87%, the current FCF yield is approximately -15.45% lower. Relative to its 5-year average FCF yield of 5.39% , the current FCF yield is about -7.96% lower.
P/B
Median3y
2.21
Median5y
2.37
FCF Yield
Median3y
5.87
Median5y
5.39
Competitors Valuation Multiple
AI Analysis for ADUS
The average P/S ratio for ADUS competitors is 1.22, providing a benchmark for relative valuation. Addus Homecare Corp Corp (ADUS.O) exhibits a P/S ratio of 1.29, which is 5.91% above the industry average. Given its robust revenue growth of 25.02%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ADUS
1Y
3Y
5Y
Market capitalization of ADUS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ADUS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ADUS currently overvalued or undervalued?
Addus Homecare Corp (ADUS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.91 is considered Undervalued compared with the five-year average of 22.00. The fair price of Addus Homecare Corp (ADUS) is between 145.51 to 190.87 according to relative valuation methord. Compared to the current price of 112.33 USD , Addus Homecare Corp is Undervalued By 22.80% .
What is Addus Homecare Corp (ADUS) fair value?
ADUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Addus Homecare Corp (ADUS) is between 145.51 to 190.87 according to relative valuation methord.
How does ADUS's valuation metrics compare to the industry average?
The average P/S ratio for ADUS's competitors is 1.22, providing a benchmark for relative valuation. Addus Homecare Corp Corp (ADUS) exhibits a P/S ratio of 1.29, which is 5.91% above the industry average. Given its robust revenue growth of 25.02%, this premium appears sustainable.
What is the current P/B ratio for Addus Homecare Corp (ADUS) as of Jan 09 2026?
As of Jan 09 2026, Addus Homecare Corp (ADUS) has a P/B ratio of 1.85. This indicates that the market values ADUS at 1.85 times its book value.
What is the current FCF Yield for Addus Homecare Corp (ADUS) as of Jan 09 2026?
As of Jan 09 2026, Addus Homecare Corp (ADUS) has a FCF Yield of 4.96%. This means that for every dollar of Addus Homecare Corp’s market capitalization, the company generates 4.96 cents in free cash flow.
What is the current Forward P/E ratio for Addus Homecare Corp (ADUS) as of Jan 09 2026?
As of Jan 09 2026, Addus Homecare Corp (ADUS) has a Forward P/E ratio of 15.91. This means the market is willing to pay $15.91 for every dollar of Addus Homecare Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Addus Homecare Corp (ADUS) as of Jan 09 2026?
As of Jan 09 2026, Addus Homecare Corp (ADUS) has a Forward P/S ratio of 1.29. This means the market is valuing ADUS at $1.29 for every dollar of expected revenue over the next 12 months.